Murine CD4 T cells produce a new form of TGF-β as measured by a newly developed TGF-β bioassay

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Oida, Takatoku ^a,b   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BIOLEGEND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; CD32 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; FC RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LUCIFERASE; MONOCLONAL ANTIBODY; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; SMAD2 PROTEIN, MOUSE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BIOASSAY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELL STRAIN HEK293; CELL TYPE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; REPORTER GENE; SIGNAL TRANSDUCTION; SUPERNATANT; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL FRACTIONATION; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SERODIAGNOSIS;

MURINAE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD86; BIOLOGICAL ASSAY; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, REPORTER; GENETIC VECTORS; HUMANS; MICE; NEUTRALIZATION TESTS; ORGAN SPECIFICITY; PHOSPHORYLATION; RECEPTORS, IGG; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 79954459142     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018365     Document Type: Article

References (23)

1. Rubtsov YP, Rudensky AY, (2007) TGFβ signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7: 443-453.
2. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, et al. (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90: 770-774.
3. Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, et al. (1994) Immune dysregulation in TGF-β1-deficient mice. J Immunol 153: 1936-1946.
4. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, (2006) TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
5. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, et al. (2006) Transforming growth factor-β induces development of the TH17 lineage. Nature 441: 231-234.
6. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
7. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, et al. (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483.
8. Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
9. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, et al. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177: 566-573.
10. Nakae S, Nambu A, Sudo K, Iwakura Y, (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 17: 6173-6177.
11. Li MO, Wan YY, Flavell RA, (2007) T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579-591.
12. Miyazono K, Ichijo H, Heldin CH, (1993) Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors 8: 11-22.
13. Nakamura K, Kitani A, Strober W, (2001) Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 194: 629-644.
14. Oida T, Weiner HL, (2010) TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. PLoS ONE 5: e15523.
15. Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, et al. (2009) Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133.
16. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, et al. (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 106: 13445-13450.
17. Stockis J, Colau D, Coulie PG, Lucas S, (2009) Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur J Immunol 39: 3315-3322.
18. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
19. Docagne F, Colloc'h N, Bougueret V, Page M, Paput J, et al. (2001) A soluble transforming growth factor-β (TGF-β) type I receptor mimics TGF-β responses. J Biol Chem 276: 46243-46250.
20. Oida T, Weiner HL, (2010) Depletion of TGF-β from fetal bovine serum. J Immunol Methods 362: 195-198.
21. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, et al. (1994) An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284.
22. Oida T, Xu L, Weiner HL, Kitani A, Strober W, (2006) TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol 177: 2331-2339.
23. Oida T, Weiner HL, (2010) Overexpression of TGF-β1 gene induces cell surface localized Glucose-Regulated Protein 78-associated Latency-associated peptide/TGF-β. J Immunol 185: 3529-3535.